Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biontech Se ADR
(NQ:
BNTX
)
113.41
-0.60 (-0.53%)
Streaming Delayed Price
Updated: 3:24 PM EDT, Oct 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
577,603
Open
112.61
Bid (Size)
113.34 (7)
Ask (Size)
113.57 (7)
Prev. Close
114.01
Today's Range
110.90 - 114.57
52wk Range
76.53 - 131.49
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising?
October 24, 2024
This drugmaker's lead candidate could become a top-selling cancer therapy.
Via
The Motley Fool
FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment
October 21, 2024
BioNTech's Phase 3 NSCLC trial is paused after varying outcomes. Current participants continue treatment, and other trials remain unaffected.
Via
Benzinga
Exposures
Product Safety
Performance
YTD
+0.95%
+0.95%
1 Month
-4.51%
-4.51%
3 Month
+30.75%
+30.75%
6 Month
+27.69%
+27.69%
1 Year
+21.62%
+21.62%
More News
Read More
BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024
October 21, 2024
From
BioNTech SE
Via
GlobeNewswire
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
October 17, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Forecasting The Future: 15 Analyst Projections For BioNTech
October 07, 2024
Via
Benzinga
Forecasting The Future: 8 Analyst Projections For BioNTech
September 13, 2024
Via
Benzinga
Market Whales and Their Recent Bets on BNTX Options
September 13, 2024
Via
Benzinga
GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement
October 15, 2024
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
Pfizer Jumps After Activist Investor Starboard Reportedly Takes $1 Billion Stake
October 07, 2024
Via
Investor's Business Daily
4 Reasons Pfizer Could Be a Value Play You Can't Miss
October 07, 2024
Via
MarketBeat
Exposures
COVID-19
Product Safety
Uber To Rally Over 33%? Here Are 10 Top Analyst Forecasts For Monday
October 07, 2024
Via
Benzinga
Consumer Tech News (Sept 30-Oct 4): Latest Windows 11 Update Causing Trouble, Apple Accused Of Compelling Employees To Sign Illegal Agreements & More
October 06, 2024
Via
Benzinga
Topics
Artificial Intelligence
Law Enforcement
Exposures
Artificial Intelligence
Legal
Google DeepMind, BioNtech Unveil AI Lab Assistants To Revolutionize Scientific Research
October 02, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day
October 01, 2024
From
BioNTech SE
Via
GlobeNewswire
Exxon Mobil To $120? Here Are 10 Top Analyst Forecasts For Tuesday
September 24, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Via
Benzinga
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
Via
Benzinga
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
September 20, 2024
From
Pfizer Inc.
Via
Business Wire
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
September 20, 2024
From
BioNTech SE
Via
GlobeNewswire
How BioNTech, Up 25% Over Four Days, Is Riding Summit's Coattails To A Recovery
September 17, 2024
Via
Investor's Business Daily
BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024
September 17, 2024
From
BioNTech SE
Via
GlobeNewswire
Here's Why Everyone's Talking About Summit Therapeutics
September 17, 2024
Via
The Motley Fool
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
September 16, 2024
Via
Benzinga
Exposures
COVID-19
Chewy, Broadcom And MicroStrategy Are Among Top 10 Large Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
September 15, 2024
Via
Benzinga
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.